Structure Therapeutics (GPCR) Deferred Taxes (2022)
Structure Therapeutics' Deferred Taxes history spans 1 years, with the latest figure at -$115000.0 for Q2 2022.
- Deferred Taxes came in at -$115000.0 for Q2 2022, down from -$6000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of -$6000.0 in Q1 2022 to a low of -$115000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 96.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -115,000.00 |
| Mar 31, 2022 | -6,000.00 |